Routine inducement grant for a single new hire — no trading signal. Monitor upcoming pipeline catalysts (ATR 1072 Phase 1/2 trial initiation) for material events.
Price Chart
Executive Summary
Atrium Therapeutics granted inducement stock options and RSUs to one new non-executive employee under its 2026 Inducement Plan, covering 13,500 options at $8.95/share and 6,750 RSUs. This is a routine hiring incentive with no material financial impact.
Key Facts
- Inducement grants awarded on September 20, 2026 to one non-executive new hire.
- Non-qualified stock options to purchase 13,500 shares at $8.95 per share (closing price on last trading day before grant).
- Restricted stock units for 6,750 shares.
- Options vest 25% on first anniversary, then 36 equal monthly installments; RSUs vest 25% on first anniversary, then 3 equal annual installments.
- Grants approved by independent directors under Nasdaq Listing Rule 5635(c)(4).
Financial Impact
13,500 options + 6,750 RSUs to a single non-executive employee; no material financial impact.
Risk Factors
- Minimal dilution from 20,250 total shares; immaterial relative to outstanding shares.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302885162 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | Press Release | $8.00 | awaiting T+5 | — | $8.05 (+0.63%) |
Oct 9, 2026 17d ago | 8-K/A | $8.40 $7.67 | ▼ −8.69% | ▼ −6.72% | $8.05 (−4.17%) |
Oct 8, 2026 18d ago | 8-K | $8.26 $7.82 | ▲ +5.33% | ▲ +5.05% | $8.05 (+2.54%) |
Sep 21, 2026 5w ago | Press Release | $9.22 $8.42 | ▼ −8.68% | ▼ −7.49% | $8.05 (−12.69%) |
Aug 20, 2026 9w ago | Press Release | $13.20 $13.64 | ▲ +3.33% | ▲ +2.86% | $8.05 (−39.02%) |
Aug 13, 2026 10w ago | 8-K | $12.84 $13.20 | ▲ +2.80% | ▲ +4.17% | $8.05 (−37.31%) |
Aug 13, 2026 10w ago | Press Release | $12.84 $13.20 | ▲ +2.80% | ▲ +4.17% | $8.05 (−37.31%) |
Jul 20, 2026 14w ago | Press Release | $12.29 $11.57 | ▼ −5.86% | ▼ −4.63% | $8.05 (−34.50%) |
Jul 14, 2026 14w ago | 8-K | $12.30 $12.17 | ▼ −1.06% | ▼ −0.08% | $8.05 (−34.55%) |
May 14, 2026 23w ago | 8-K | $13.23 $13.09 | ▼ −1.06% | ▼ −2.02% | $8.05 (−39.15%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers